CTRI/2022/11/047205尚未招募未知
To develop NEAR AI, a model to predict response to immune checkpoint inhibitor therapy in Non Small Cell Lung carcinoma (NSCLC).
Kerala Startup Mission0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Non small cell carcinoma lung of any histology who have received treatment with immune checkpoint inhibitor therapy between 2017-2021.
- •2. Patients should have taken regular treatment as per prescribed protocol for at least 3 months or till first radiological response assessment by iRESIST, whichever is later.
- •3. Drug treatments include Pembrolizumab/Nivolumab/Durvalumab/Atezolizumab either in combination with chemotherapy or as single agents.
- •4. Stage IV or recurrent disease.
- •5. Any line of treatment is included
- •6. Combination with radiation is included
- •7. Hematoxylin â?? Eosin slide with/without corresponding FFPE block of tumor biopsy tissue is available.
- •8. Clinical record of response to ICI therapy is available.
排除标准
- •1. Documented infectious pneumonia during first 3 months of therapy.
研究者
相似试验
招募中
Unknown
Artificial Intelligence Predicts Refractory Septic Shock in Sepsis Patients: A Validated Model for Early predictioCTRI/2024/06/069604Mukkelli Vinay Gandhi
已完成
不适用
Development of an AI-based system for predicting falls and fall-related injuries in hospitalsone (All patients admitted during the study period)JPRN-UMIN000041289Fujita Health University69,291
已完成
不适用
Development and exploration of an AI model to classify healthy subject and suspected schizophrenia patient based on free conversations with medical staffSchizophreniaJPRN-jRCT1030210514Yuichiro Tsutsumi150
招募中
不适用
Development and exploration of an AI model to classify schizophrenia with signs of relapse and schizophrenia with no signs of relapse based on free conversations with medical staffSchizophreniaJPRN-jRCT1030220320Toyoshiba Hiroyoshi100
尚未招募
Unknown
Artificial Intelligence Approach to Early Detection of Breast and Cervical Cancers in Indian Patients.CTRI/2024/04/065171AIIMS New Delhi